Ingrid Schoenmakers

Janssen Europe, Middle East & Africa (EMEA)

Who is Janssen EMEA? We're people; more than 14,000, working hard to treat, cure, stop and prevent some of the most devastating and complex diseases of our time — from diabetes and HIV, to Alzheimer's and cancer. Janssen is the pharmaceutical arm of Johnson & Johnson, one of the world's leading global healthcare companies. We are dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolism. We are driven to action by the plight of patients, and we aspire to make a positive impact on their lives. That's why we never limit the search for new medicines to our own four walls—we're always looking to work with partners interested in helping us achieve our goals. Success for us doesn't stop in our labs. The world is our lab, and we wouldn't be able to succeed if it weren't for our approach to collaboration. We work closely with like-minded people from researchers to governments, healthcare professionals to patient organisations. And we work with them at every stage, from early discovery to market access and patient education. We seek medical breakthroughs wherever they occur. Whether you're at a university, a research organisation, or another biotech or pharmaceutical company, we want to hear from you. We are Janssen. We collaborate with the world for the health of everyone in it.